Pneumococcal Vaccines Global Medical Affairs Lead, non

ROLE SUMMARY

This position will assume a senior role within the MDSCA pneumococcal vaccines asset, supervising a team of pneumococcal vaccine medical affairs experts within the Global Respiratory Vaccines Franchise. This team supports medical affairs activities globally, within the global pneumococcal asset for the current (PCV13 and PCV20) and next generation pneumococcal conjugate vaccines (PNG) for both pediatric and adult use. The position is responsible for the development and implementation of a single, aligned global medical position on scientific and medical issues relevant for pneumococcal vaccines and to integrate these data into Medical Affairs outputs. This will be achieved by integration with different functional areas within the pneumococcal vaccines franchise (vaccine research and development, health outcomes, commercial, regulatory, safety, public affairs) at the global and local levels, and coordinating work and strategies where appropriate with KOLs and external scientists. The Medical Affairs team also ensures medical input into critical documents such as regulatory filings and communications, press releases, and internal position statements. The Medical Affairs team also leads studies and publishes manuscripts, generally summary statements and systematic literature reviews (the latter usually conducted by CROs). Depending on interest, skills and time, this position could also participate on and contribute to studies led by the Scientific Affairs team.

As a supervisory position, the incumbent must have demonstrated strong leadership skills; the ability to work within teams across numerous cross-functional areas; ability to work efficiently and effectively on highly complex subjects delivering high quality products on time; extensive network of KOLs; and expertise in critical areas. Specific expertise will include pneumococcal epidemiology; pneumococcal vaccine science; understanding the implementation and biases of field based/observational studies; regulatory issues and filings; vaccine safety; and real world data analyses. Ideally the incumbent will have expertise in designing and implementing field-based/surveillance/observational studies to allow an understanding of their limitations and biases when interpreting results of internal and external studies. Given the cross-functional and outward facing nature of this position, the incumbent must have demonstrated extensive positive feedback from colleagues and external collaborators.

ROLE RESPONSIBILITIES

• Supervise a team of Global Pneumococcal Vaccine Medical Affairs experts, including setting priorities, overseeing work, meeting on a regular basis, assessing and communicating performance, and assigning some parts of compensation (e.g., bonus levels).
• Ensuring integration of scientific information (epidemiology, carriage, disease burden, public health value, etc.) and summarize scientific evidence for Medical Affairs deliverables, in conjunction with pediatric/adult leads
• Contribute to and lead strategy and execution of publications, scientific congresses, including symposia, and advisory boards related to pneumococcal vaccines
• Provide global medical affairs support for regulatory deliverables across pediatric and adult franchises and for existing, in-line, and early phase pneumococcal vaccines.
• Develop and update slide compendiums for medical-to-medical communication as well as for internal use on key evidence related to pneumococcal disease and vaccination
• Lead and contribute to scientific manuscripts on pneumococcal disease and vaccination
• Where appropriate, integrate into and contribute to ongoing Pfizer studies led by Scientific Affairs staff
• Gather and integrate published scientific data necessary for developing pneumococcal vaccine product labels
• Participate in the scientific dialogue and positioning of pneumococcal vaccines and pneumococcal science via various avenues, including but not limited to:
• The development and execution of medical advisory boards in accordance with Pfizer policies and procedures
• Working with internal and external experts to publish data in peer-reviewed manuscripts,
• Working with internal and external experts to develop abstracts and present data for scientific congresses
• Participate in cross-functional collaborations to support adult and pediatric launches globally
• Attend and contribute to Respiratory Vaccine Franchise Leadership Team meetings

BASIC QUALIFICATIONS

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

• Advanced and relevant degree such as PhD or PharmD and 8+ years of experience (time during a doctoral program in a relevant subject area would count towards this time); for exceptional candidates we would also consider MS, MPH or nursing degree in a relevant field and 13+ years of experience (time during a doctoral program in a relevant subject area would count towards this time)
• Preference is for experience in vaccine-related or vaccine-preventable disease related medical/scientific activities
• Expertise in critical areas such as epidemiology, field based studies and their interpretation, pneumococcal and pneumococcal vaccine science, writing and publishing manuscripts, and regulatory strategies and science
• Established track record of values and compliance leadership including across diverse cultures and geographies
• While not a requirement, previous supervisory experience will be a plus; regardless, the position requires someone with commitment to and ability for supervising and leading a team.
• Strong external KOL network
• Documented ability to take a project from start to end including conception, design, protocol, analytic plan, implementation, analysis, and reporting and interpretation of results
• High degree of positive feedback from colleagues working with the incumbent in their current and previous positions.
• Able to review, evaluate, interpret, and present complex data; ability to understand information on emerging safety and efficacy profile of pneumococcal vaccines
• Understand the critical data elements related to assessing the public health value of pneumococcal vaccines, vaccine impact, and ability to interpret data and data limitations for both Pfizer and competitor pneumococcal vaccines
• Excellent verbal and written communication skills including scientific writing skills.
• Demonstrated experienced writing manuscripts, including lead or senior authorship on 3 or more peer-reviewed publications.
• Fluent in English writing, reading, speaking; multiple languages a plus but not required

NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS

Willingness to travel, both domestic and internationally; maximum would be up to 25%, minimum approximately 10%.

Last Date to Apply: August 12, 2024

This is a hybrid in-office role requiring 2-3 days on-site per week

Eligible for Relocation Package: No

The annual base salary for this position ranges from $191,300.00 to $318, In addition, this position is eligible for participation in Pfizer's Global Performance Plan with a bonus target of 22.5% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life's moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site - U.S. Benefits | ). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States.

Relocation assistance may be available based on business needs and/or eligibility.

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer. This position requires permanent work authorization in the United States.

Medical

#LI-PFE